Trademark: 97239287
Word
THUZIUM
Status
Pending
Status Code
731
Status Date
Thursday, January 25, 2024
Serial Number
97239287
Mark Type
4000
Filing Date
Wednesday, January 26, 2022
Published for Opposition
Tuesday, December 13, 2022

Trademark Owner History
Glaxo Group Limited - Owner At Publication

Classifications
5 Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders

Trademark Events
Jan 25, 2024
Sou Extension 2 Granted
Jan 25, 2024
Sou Extension 2 Filed
Jan 25, 2024
Sou Teas Extension Received
Jul 18, 2023
Notice Of Approval Of Extension Request E-Mailed
Jul 14, 2023
Sou Extension 1 Granted
Jul 14, 2023
Sou Extension 1 Filed
Jul 14, 2023
Sou Teas Extension Received
Feb 7, 2023
Noa E-Mailed - Sou Required From Applicant
Dec 13, 2022
Official Gazette Publication Confirmation E-Mailed
Dec 13, 2022
Published For Opposition
Nov 23, 2022
Notification Of Notice Of Publication E-Mailed
Nov 9, 2022
Teas Change Of Correspondence Received
Nov 9, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Nov 9, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Nov 7, 2022
Approved For Pub - Principal Register
Nov 3, 2022
Examiner's Amendment Entered
Nov 3, 2022
Notification Of Examiners Amendment E-Mailed
Nov 3, 2022
Examiners Amendment E-Mailed
Nov 3, 2022
Examiners Amendment -Written
Nov 2, 2022
Assigned To Examiner
Jan 31, 2022
New Application Office Supplied Data Entered
Jan 29, 2022
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24